Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Pluvia's Fist.com - Pluvia's Plays & Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Dale Baker who wrote (719)	6/27/2000 1:18:00 PM
From: RockyBalboa	Respond to of 1766

Dale, I was very busy with it... when it refused to go down on heavy volume I covered much at 42.5, 43 and sold some in the soon to come spike from 44s onwards. I took that back in when it dipped quickly after the STLW open. In the meantime it looks like much of the opening gap in stlw was arb'd against Meth which basically didn't move any more. From here, I expect STLW to weaken gradually ; Stlw has quite a float and, and Meth move in tandem but the volatility should remain low...as Meth was never that overpriced as for example DBCC, or BNYN, or also COMS. There is not much to win from a development in discount as a discount already persists to the tune of 45%, 50%. Had the discount been smaller (because of meth being overpriced pre IPO) then the next two weeks would usually offer some odds. Longer term it is an interesting way to get Meth for free as it is planned to separate the two entities (like mall/ubid or coms/palm) in a tax free transaction as the intrinsic STLW value (STLW 37, Meth 43) is around 55. Would I be long Meth, I would sell. Being short a small position I use a stop some bucks away or eventually would cover on a quick dip.